Next AdvaMed Chief Is BIO Exec Scott Whitaker
This article was originally published in The Gray Sheet
Whitaker, appointed as the next CEO of AdvaMed, currently runs day-to-day operations at the Biotechnology Innovation Organization and has held high-level posts at HHS. Among his accomplishments, Whitaker led the legislative office at HHS when the first device user fee bill was passed in 2002.
Register for our free email digests: